Makers of fertilizers and farm chemicals — the nutrients, pesticides and crop treatments that help farmers grow bigger, healthier harvests.
Contains
News movingFertilizers & Agricultural Chemicals
United States
Fertilizers & Agricultural Chemicals▼
Corteva Completes Spin-Off of Seed Business Into Vylor
Corteva has completed the spin-off of its seed operations into a separate entity called Vylor Inc., leaving the company focused on crop protection products and digital agriculture services while Vylor assumes the seed portfolio. Legal challenges have emerged questioning how PFAS-related obligations are allocated between Corteva and Vylor after the separation. Corteva now operates as a pure-play agriculture group across the US and multiple international regions, and its inclusion in the S&P 400, Russell Small Cap Comp Value Index and S&P 1000 moves it into a different peer group. Investors will be watching the first full year of post-spin financials to see whether the crop protection and digital operation delivers on its standalone revenue base of about US$7.5b and projected US$1.4b EBITDA for 2025.
CTVA · Capital · Neutral Corteva completed the spin-off of its seed business into Vylor, leaving it a pure-play crop protection/digital ag company with ~$7.5b revenue and $1.4b EBITDA projected for 2025.
CTVA · Regulation · Negative Legal challenges question how PFAS-related obligations are allocated between Corteva and Vylor after the separation.
VYLR · Capital · Neutral Vylor Inc. was created via the spin-off and assumes Corteva's seed portfolio, but faces legal questions over PFAS obligation allocation.
FMC Files Brazil Regulatory Dossier for Rimisoxafen Herbicide
FMC Corporation has submitted its regulatory dossier for rimisoxafen, the first dual mode of action herbicide, to Brazilian authorities, targeting resistant broadleaf weeds in major soybean and corn markets. The Brazil submission is the second global filing for rimisoxafen, following an earlier filing with the U.S. Environmental Protection Agency, and advances the company's pipeline of new proprietary herbicides. The move connects to FMC's recent exclusive supply and license agreement with Corteva around rimisoxafen, which includes a US$200 million pre-purchase and provides a commercialization pathway in corn and soybeans. FMC's narrative projects $3.9 billion in revenue and $313.5 million in earnings by 2029, requiring 6.6% yearly revenue growth and about a $3.0 billion earnings increase from -$2.7 billion today. The lowest analyst estimate assumes revenue of about US$3.8 billion and earnings of roughly US$335.0 million by 2029, citing the long, uncertain approval path for products like rimisoxafen as a key reason profits could lag.
FMC · Regulation · Positive FMC filed its Brazilian regulatory dossier for rimisoxafen, advancing the herbicide toward approval in major soybean and corn markets.
CTVA · Demand · Neutral Mentioned only as FMC's exclusive supply/license partner for rimisoxafen, with no new development of its own.
Lutianhua hit by heavy bank shareholder sell-downs; three straight years of losses excluding non-recurring items and a letter-of-credit lawsuit still hanging over it
Lutianhua recently announced that Agricultural Bank of China Ningxia Branch holds 53.86 million shares, or 3.43% of total share capital, and plans to reduce its stake by 15.68 million shares, or 1% of total share capital. Bank shareholders have already carried out several rounds of reductions: on August 20, Bank of China Luzhou Branch and its concert parties Bank of China Chengdu Branch and Bank of China Ningxia Branch completed a reduction of 14.43 million shares, or 0.92%; in February, the same concert parties completed a reduction of 8.18 million shares, or about 0.522%; in April, Agricultural Bank of China Sichuan Branch completed a reduction of 15.68 million shares, or 1%. Behind the bank shareholders' exit, the company posted first-half 2026 revenue of 2.189 billion yuan, down 8.03% year on year, net profit attributable to the parent of 8.28 million yuan, down 76% year on year, and a net loss attributable to the parent excluding non-recurring items of 10.64 million yuan, down 203% year on year. In 2025, revenue was 4.495 billion yuan, down 11.34% year on year, with a net loss excluding non-recurring items of 38.43 million yuan. In 2024, revenue was 5.069 billion yuan, down 21% year on year, with a net loss excluding non-recurring items of 19.28 million yuan. Excluding non-recurring items, the company has now been loss-making for three consecutive years, and its book profit is highly dependent on government subsidies. At the industry level, domestic urea capacity in 2025 was 80.8 million tonnes, up 4.65% from 2024, with output expected at 71.7 million tonnes, up 10.88% year on year, while consumption was 62.2 million tonnes, cementing an oversupply pattern. Urea spot prices fell from 2,228 yuan per tonne at the end of 2024 to 1,995 yuan per tonne at the end of June 2026. The company's designed methanol capacity is 700,000 tonnes, but its capacity utilisation rate in 2025 was only 36.1%, while the utilisation rate for automotive urea was 19.4%. Its wholly owned subsidiary Lutianhua Import and Export Trading Company has been drawn into a letter-of-credit fraud lawsuit. After losing at first instance, it has appealed. If it ultimately loses, the overall loss would be 68.1585 million yuan. So far, it has cumulatively made provisions for impairment of 27.1035 million yuan, with an additional provision of 6.9757 million yuan in the first half of 2026. As of the end of July, the actual guarantee balance of the company and its controlled subsidiaries was 533 million yuan, accounting for 8.40% of the latest audited net assets, of which guarantees involved in litigation amounted to 60 million yuan.
000912.CS · Capital · Negative Bank shareholders plan further stake reductions after three straight years of losses excluding non-recurring items and a 76% drop in H1 2026 net profit.
000912.CS · Supply · Negative Domestic urea oversupply (capacity up 4.65%, output up 10.88% vs consumption) pushed spot prices down to 1,995 yuan/tonne, pressuring the company's core product.
Hubei Yihua's 2×30,000-ton anhydrous hydrogen fluoride project phase one goes into production
Hubei Yihua announced that its controlling subsidiary Yihua Fluorochemicals has completed one 30,000-ton-per-year anhydrous hydrogen fluoride unit under phase one of the 2×30,000-ton-per-year anhydrous hydrogen fluoride project, and it has safely and smoothly gone into production after review. The project converts fluorosilicic acid, a by-product of phosphorus chemicals, into high-value-added anhydrous hydrogen fluoride, helping optimize the phosphorus-fluorine product structure and enhance the company's competitiveness. The company said phase two will be implemented at an appropriate time based on market demand.
000422.CS · Supply · Positive Hubei Yihua's subsidiary completed and started up a 30,000-ton/year anhydrous hydrogen fluoride unit, adding high-value capacity from fluorosilicic acid by-product.
Yihua Fluorochemical · Supply · Positive Yihua Fluorochemicals brought its phase-one 30,000-ton/year anhydrous hydrogen fluoride unit safely into production, boosting its output capacity.
ScottsMiracle-Gro Names Prathima Hegde Chief Information Officer
The Scotts Miracle-Gro Company has named Prathima Hegde as senior vice president and chief information officer, the company announced. Hegde will lead enterprise IT with a focus on technology modernization, operational excellence, AI integration and digital capabilities, and will support the implementation of SAP S/4HANA. She reports to President and CEO Nate Baxter as a key member of the leadership team. Hegde joins from Del Monte Foods, where she served as CIO and led enterprise IT strategy, cloud modernization, data analytics and AI initiatives, and previously led the technology spinoff from PepsiCo as head of corporate applications at Tropicana Brands Group. The appointment supports the company's multi-year SMG 2.0 growth strategy, whose building blocks include portfolio optimization and innovation, omnichannel and retail expansion, category and market expansion, and technology-driven operational excellence. ScottsMiracle-Gro, which has approximately $3.3 billion in sales, is the leading marketer of branded consumer lawn and garden products in North America.
SMG · Technology · Positive Appoints a new CIO to lead IT modernization, AI integration and SAP S/4HANA implementation supporting its SMG 2.0 strategy.
SAP.XETRA · Demand · Positive ScottsMiracle-Gro's planned SAP S/4HANA implementation is a product adoption for SAP.
J.P. Morgan Upgrades Corteva to Overweight After Vylor Spinoff, Sets $19 Target
J.P. Morgan upgraded Corteva to Overweight from Neutral on Tuesday, arguing that the agricultural-chemicals company left behind after the spinoff of its seed business is undervalued and has a stronger financial profile than its share price suggests. Lead analyst Jeffrey J. Zekauskas set a December 2027 price target of $19, compared with Corteva's Oct. 5 closing price of $12.39, implying upside of about 53%; the sharp reduction from J.P. Morgan's previous $83 target reflects the separation of Corteva's seed business into Vylor rather than a comparable collapse in the bank's assessment of the underlying company. The new Corteva consists of the former company's crop-chemicals operations, which J.P. Morgan estimates has a gross margin of about 38%, ebitda margins of 16.5% to 17% and negligible net debt, with the shares trading at roughly 5.7 times estimated 2027 ebitda, about one turn below rival FMC despite FMC carrying substantially more leverage. Zekauskas estimates a high-quality crop-chemicals business could ordinarily warrant about 10 times 2027 ebitda, equivalent to roughly $21 a share before environmental liabilities, but J.P. Morgan uses a more conservative 9-times multiple to reach its $19 target, accounting for uncertainty over PFAS and PFOA liabilities inherited from the former DuPont structure; it models a conservative scenario in which combined liabilities for DuPont, Chemours and Corteva reach $8 billion, twice the existing $4 billion framework, putting Corteva's responsibility at about $1.3 billion, or roughly $2 a share. J.P. Morgan forecasts Corteva revenue rising from $7.87 billion in 2026 to $8.10 billion in 2027, adjusted ebitda increasing from $1.28 billion to $1.37 billion, adjusted EPS climbing 31.6% to 85 cents in 2027 and free cash flow to the firm jumping to $542 million from an estimated $63 million this year, with potential catalysts including $300 million in run-rate savings targeted from 2024 through 2027 and $500 million by 2029, plus a recovery in grain prices.
CTVA · Capital · Positive J.P. Morgan upgraded Corteva to Overweight and set a $19 price target, calling the post-Vylor crop-chemicals business undervalued at ~5.7x 2027 EBITDA.
FMC · Competition · Neutral FMC is named only as a valuation comparison, with Corteva trading about one turn below FMC despite FMC carrying substantially more leverage.
Nutrien to Indefinitely Shut Trinidad Nitrogen Operations
Nutrien Ltd. announced it will indefinitely shut down its Trinidad Nitrogen operations at the Point Lisas Facility following a comprehensive review of strategic alternatives and discussions with relevant stakeholders. The decision responds to ongoing natural gas constraints and supply uncertainty and is aimed at reducing pressure to enhance free cash flow and return on invested capital. Nutrien had previously implemented a controlled shutdown of the facility on Oct. 23, 2025, due to port access restrictions and a lack of reliable and economic natural gas supply, and it determined that permanently halting operations was the optimal path. The shutdown should not affect Nutrien's 2026 nitrogen sales volume guidance, which was maintained at 9.2-9.7 million tons, because the company had already assumed no production from Trinidad's operations. On its second-quarter call, the company raised its 2026 Potash sales volume guidance to 14.2-14.8 million tons from 14.1-14.8 million tons, while Phosphate sales volume guidance remains 2.4-2.6 million tons and global potash shipments are projected at 74-77 million tons for 2026.
NTR · Supply · Positive Nutrien indefinitely shuts its Trinidad nitrogen operations due to natural gas constraints, cutting high-cost capacity and easing pressure to improve free cash flow and ROIC.
Nutrien to Indefinitely Shut Trinidad Nitrogen Operations at Point Lisas
Nutrien Ltd. announced it will indefinitely shut down its Trinidad Nitrogen operations at the Point Lisas Facility following an extensive review of strategic alternatives and engagement with relevant stakeholders. The company said ongoing natural gas constraints and uncertainty made the closure the optimal path to enhance free cash flow and return on invested capital. Nutrien had previously implemented a controlled shutdown of the facility on October 23, 2025, in response to port access restrictions and a lack of reliable and economic natural gas supply that reduced the free cash flow contribution of the Trinidad Nitrogen operations over an extended period. Dean Perkins, Senior Vice President, Upstream, Nitrogen and Proprietary Product Operations, said the company appreciates the contributions and dedication of its Trinidad team and is committed to managing the transition responsibly and safely. Nutrien said there will be no impact to its 2026 Nitrogen sales volume guidance because the company assumed no production from its Trinidad Nitrogen operations, and it remains well positioned to meet customer demand for nitrogen and grow volumes from its North American Nitrogen assets through reliability improvements and low-cost debottleneck projects.
NTR · Supply · Positive Nutrien is indefinitely shutting its Trinidad nitrogen facility due to natural gas constraints, cutting high-cost capacity and improving free cash flow without affecting 2026 sales guidance.
American Vanguard names Matt Horwath as CFO in planned leadership transition
American Vanguard announced on October 1, 2026 that Matt Horwath will join the company as Chief Financial Officer effective October 1, 2026, succeeding David Johnson as part of a planned leadership transition. David Johnson will remain with the company as Chief Accounting Officer through March 2027 and will continue in a non-executive role until September 2027. Horwath joins American Vanguard with nearly 20 years of finance, accounting and public company leadership experience, most recently serving as Chief Financial Officer of Kustom US, Inc.
Vicor, Inogen, Alphabet Rise; Corteva Drops 64% on Vylor Spinoff
Vicor, Inogen and Alphabet were among Thursday's biggest stock gainers, while Corteva led decliners. Vicor shares jumped 10% after the company raised its Q3 sequential growth guidance to more than 30% from its previous outlook of more than 20%, reflecting increased royalties from its first non-exclusive license for vertical power delivery technology. Inogen shares surged 8% after the company agreed to divest its U.S. oxygen rental business to Rotech Healthcare for total estimated cash consideration of up to $25M, a deal expected to close in Q4 2026, alongside a long-term supply agreement with Rotech; the rental business generated $24.3M in revenue in 1H 2026, down 9.8% Y/Y, and Inogen increased its share repurchase authorization by $15M to $45M, expiring June 30, 2028. Alphabet shares edged higher 4% after Google provided a first look at Gemini 4 Argon, its latest frontier AI model, which outperformed OpenAI Astra and Anthropic Fable 5.1 and Opus 5.5 in 13 of 19 benchmarks, including a 77.9% score on DeepSWE v1.1, and will cost $2 per million input tokens and $10 per million output tokens when launched. Corteva shares dropped 64% following the planned tax-free separation of its Crop Protection business into an independent publicly traded company, Vylor, a decline reflecting the mechanical price adjustment associated with the distribution rather than a conventional sell-off, with the separation effective October 1.
CTVA · Capital · Negative Corteva dropped 64% on the planned tax-free spinoff of its Crop Protection business into Vylor, a mechanical price adjustment tied to the distribution.
GOOG · Technology · Positive Google unveiled Gemini 4 Argon, its new frontier AI model, which outperformed rival models on 13 of 19 benchmarks.
INGN · Capital · Positive Inogen agreed to divest its U.S. oxygen rental business to Rotech for up to $25M and raised its share repurchase authorization by $15M.
VICR · Capital · Positive Vicor raised its Q3 sequential growth guidance to more than 30% on increased royalties from its first non-exclusive vertical power delivery license.
FMC Files Rimisoxafen Herbicide for Approval in Brazil
FMC Corporation has submitted a regulatory dossier for rimisoxafen to Brazilian authorities, the second global regulatory submission for the herbicide after its filing with the U.S. Environmental Protection Agency in July 2026. Brazil is one of the world's largest soybean and corn producers, with more than 50 million hectares of soybeans and more than 20 million hectares of corn under cultivation, where growers are increasingly battling resistant broadleaf weeds including Amaranthus hybridus and Amaranthus palmeri. The Herbicide Resistance Action Committee classified rimisoxafen under Groups 12 and 32, and as the first dual mode of action herbicide its field testing has shown consistent activity against small-seeded broadleaf weeds, including those resistant to other herbicides. Rimisoxafen is the third novel herbicide active ingredient FMC has advanced to regulatory submission in Brazil, following Isoflex and Dodhylex, though it remains subject to regulatory review and approval and is not currently registered for sale or use in Brazil or any other country. FMC shares have slumped 72.6% in the past year compared with the industry's 10% growth in the same period.
FMC · Regulation · Positive FMC filed its rimisoxafen herbicide dossier with Brazilian regulators, advancing a novel active ingredient toward approval in a major crop market
Corteva and Inari announced they have reached a confidential settlement agreement to resolve the lawsuit Corteva filed in September 2023 in the United States District Court for the District of Delaware. Under the settlement, Inari has agreed to destroy Corteva material it accessed from seed depositories, along with material developed from those deposits, and to assign to Corteva the intellectual property related to its edited versions of Corteva events. The two companies also agreed to negotiate certain licensing arrangements, while the remaining terms of the settlement stay confidential. The case is Corteva Agriscience LLC, Pioneer Hi-Bred International, Inc., and Agrigenetics, Inc. v. Inari Agriculture, Inc. and Inari Agriculture NV, C.A. No. 23-1059 (JFM). Corteva and Inari said the rulings reinforce applicable rights over seed deposits and that it is important to abide by applicable patent and other laws and contracts relating to deposited materials.
CTVA · Regulation · Positive Corteva won a settlement forcing Inari to destroy Corteva seed material and assign related IP, reinforcing its patent/contract rights over seed deposits.
OCI Global Posts USD 1 Million H1 2026 Profit as Orascom Combination Advances
OCI Global reported net profit attributable to shareholders of USD 1 million in H1 2026, down from USD 343 million in H1 2025, as the company advanced the final stages of its strategic review. The H1 2026 result includes a USD 238 million gain on the disposal of OCI Ammonia Holding, largely offset by an impairment charge at OCI Nitrogen, while the prior-year result included a USD 688 million gain on the sale of OCI Methanol. The OCI Nitrogen segment reported revenue of USD 534 million, down from USD 566 million a year earlier, but operating profit rose to USD 53 million from a loss of USD 21 million, even as the segment posted negative free cash flow of USD 2 million and a net loss attributable to shareholders of USD 175 million following a USD 215 million non-cash impairment charge. Management estimates adjusted EBITDA of approximately USD 8 million and negative free cash flow of USD 16 million for July and August 2026, and expects less favourable market conditions for the remainder of the year. On the strategic front, NNS Holding (Cyprus) Limited's all-cash public offer for all OCI shares at EUR 4.10 per share opened on 15 September 2026 and closes on 17 November 2026, while an extraordinary general meeting is set for 30 October 2026 to vote on the proposed combination with Orascom Construction, which is expected to complete in Q4 2026. Held-for-sale net cash stood at USD 1.05 billion as of 30 June 2026, compared with net debt of USD 54 million on 31 December 2025.
OCI.AS · Capital · Neutral OCI Global's H1 2026 profit collapsed to USD 1 million from USD 343 million, with impairment charges and weak outlook offset by the NNS EUR 4.10/share offer and Orascom combination.
OCI Nitrogen · Capital · Neutral OCI Nitrogen revenue fell to USD 534 million but operating profit swung to USD 53 million, though a USD 215 million impairment drove a USD 175 million net loss.
OCI Ammonia Holding · Capital · Positive OCI Ammonia Holding's disposal generated a USD 238 million gain in H1 2026, largely offsetting the OCI Nitrogen impairment.
OCI Methanol · Capital · Neutral OCI Methanol is referenced only as the source of the prior-year USD 688 million disposal gain, not as a current operating segment.
Lanfeng Biochemical terminates 2023 private placement, plans new share issue to raise up to 300 million yuan for debt repayment
Lanfeng Biochemical announced that its board of directors has approved the termination of the 2023 private placement of A-shares to specific investors, and approved a 2026 private placement plan. The total proceeds will not exceed 300 million yuan, and after deducting issuance expenses, all funds will be used to repay loans from financial institutions.
ST Site Discloses Rectification Report on Financial Fraud; Ningguo Agricultural Materials' 36.8063 Million Yuan in Occupied Funds Not Yet Returned
ST Site announced on the evening of September 27 a rectification report regarding the Anhui Securities Regulatory Bureau's order for corrective measures. The company had multiple issues including illegal use of non-public offering proceeds, illegal lending of funds to related parties, inaccurate periodic report disclosures, and imperfect corporate governance and internal controls. Some funds occupied by related parties have still not been recovered. The rectification report shows that from 2016 to 2019, the company illegally used non-public offering proceeds involving 115 million yuan, causing losses of 33.0146 million yuan. Its wholly owned subsidiary Xinhong Grand Health illegally lent 110 million yuan to Dongchen Health under the guise of custody. The company also engaged in fabricating engineering projects, revenues, and costs, resulting in false financial data disclosures for 2024 and prior years. The Anhui Securities Regulatory Bureau had previously ordered the company to make corrections, issued a warning, and imposed a fine of 6 million yuan. It also issued warnings to seven individuals including then chairman Jin Guoqing and then general manager Jin Zhenghui, with combined fines of 12.6 million yuan. Regarding fund recovery, the company required Ningguo Agricultural Materials to return all occupied funds and pay occupation fees by September 27, 2026, but as of now Ningguo Agricultural Materials has not returned them, involving 36.8063 million yuan. Dongchen Health still has 32 million yuan in occupied funds unrecovered, and Xuancheng Orthopedic Hospital has been ruled into bankruptcy reorganization. The company stated that the above fund occupation is non-operating fund occupation by other related parties and will not cause the company to trigger relevant provisions of the Shenzhen Stock Exchange stock listing rules, and trading of its shares will not be suspended.
002538.CS · Regulation · Negative Anhui Securities Regulatory Bureau ordered corrective measures and fined the company 6 million yuan for illegal use of proceeds, related-party lending, and false disclosures.
安徽省宁国市农业生产资料有限公司 · Capital · Negative Ningguo Agricultural Materials has not returned 36.8063 million yuan in occupied funds owed to ST Site by the September 27, 2026 deadline.
安徽省鑫宏大健康产业管理有限公司 · Regulation · Negative Xinhong Grand Health illegally lent 110 million yuan to Dongchen Health under the guise of custody, part of the violations cited in the rectification report.
宣城东晨健康产业管理有限公司 · Capital · Negative Dongchen Health still has 32 million yuan in occupied funds unrecovered from its illegal custody lending arrangement with Xinhong Grand Health.
宣城骨科医院 · Capital · Negative Xuancheng Orthopedic Hospital has been ruled into bankruptcy reorganization, leaving its occupied funds unrecovered.
Lanfeng Biochemical Plans Private Placement of No More Than 300 Million Yuan to Repay Financial Institution Borrowings
Lanfeng Biochemical announced on September 28 that the company plans to issue shares to specific investors to raise total proceeds of no more than 300 million yuan, which after deducting issuance expenses will be used entirely to repay borrowings from financial institutions. The subscribers for this issuance are Xugu Capital and Anhui Ximing, with Xugu Capital being the controlling shareholder of Anhui Ximing, and the company's controlling shareholder and actual controller Zheng Xu being the actual controller of this issuance. At the same time, the company decided to terminate the 2023 private placement of A-shares to specific investors.
Sichuan Meifeng subsidiary to sign RMB 79.2 million vehicle urea supply contract
Sichuan Meifeng announced on September 27 that its wholly owned subsidiary Sichuan Meifeng Jialan Environmental Protection Technology Co., Ltd. plans to sign a Chemical Products Framework Procurement Contract Agreement with Tianjin Sinopec Yuetai Technology Co., Ltd., under which Jialan will supply diesel vehicle exhaust treatment fluid, namely vehicle urea solution, to Tianjin Yuetai. The contract is expected to cover a supply volume of 60,600 tonnes, with an estimated value of approximately RMB 79.2 million. The contract is valid from the date of signing until August 31, 2028.
Sichuan Meifeng wholly-owned subsidiary to sign procurement contract worth 79.2 million yuan
Sichuan Meifeng announced that its wholly-owned subsidiary Jialan Company plans to sign a Framework Procurement Contract for Chemical Products with Tianjin Yuetai, under which Jialan Company will supply diesel vehicle exhaust treatment fluid to Tianjin Yuetai, with an expected supply volume of 60,600 tonnes and an estimated contract value of approximately 79.2 million yuan. Since Tianjin Yuetai and Sichuan Meifeng's controlling shareholder are both controlled by China Petrochemical Corporation, this transaction constitutes a related-party transaction. The matter is to be submitted to the company's board of directors for deliberation and does not require approval by the shareholders' meeting.
000731.CS · Demand · Positive Wholly-owned subsidiary Jialan will supply 60,600 tonnes of diesel exhaust treatment fluid to Tianjin Yuetai under a ~79.2 million yuan procurement contract.
Corteva Says SEC Declares Vylor Form 10 Effective Ahead of October 1 Spinoff
Corteva announced that the U.S. Securities and Exchange Commission has declared effective Vylor's Registration Statement on Form 10, clearing the way for Vylor to separate into an independent, publicly traded company expected to be completed on October 1, 2026. Upon completion of the separation, each Corteva stockholder of record as of the close of business on September 24, 2026 will receive one share of Vylor common stock for every share of Corteva common stock held of record at that time. The distribution is expected to occur prior to 9:30 a.m. New York City time on October 1, 2026. Vylor common stock has been authorized for listing on the New York Stock Exchange and is expected to begin regular-way trading under the symbol VYLR on October 1, 2026. Corteva said there will not be when-issued trading in Vylor common stock or ex-distribution trading in Corteva common stock prior to the distribution.
CTVA · Capital · Neutral SEC declares Vylor Form 10 effective, clearing the way for the October 1, 2026 spinoff of Vylor from Corteva.
Vylor Inc. · Capital · Positive Vylor's Form 10 declared effective, enabling its separation into an independent NYSE-listed company (VYLR) on October 1, 2026.
Lubei Chemical to inject 209 million yuan to advance 200,000-tonne titanium dioxide project
Lubei Chemical announced that its board of directors has approved a proposal to inject 209 million yuan into its controlled grandson company Shandong Yuanhai New Material Technology through its wholly owned subsidiary Shandong Jinhai Titanium Resources Technology, in order to safeguard the construction schedule of the first phase of the green production project with an annual capacity of 200,000 tonnes of co-production titanium dioxide. At the same time, the board supplemented and confirmed the related-party transaction with an affiliate for the joint research and development of a new hydrochloric acid process for titanium dioxide production.
600727.CG · Capital · Positive Lubei Chemical's board approved a 209 million yuan injection into its titanium dioxide project to keep construction on schedule.
Shandong Yuanhai New Materials Technology Co., Ltd. · Capital · Positive Yuanhai New Material receives the 209 million yuan capital injection for the 200,000-tonne titanium dioxide project.
Shandong Jinhai Titanium Resources Technology Co., Ltd. · Capital · Positive Jinhai Titanium Resources Technology is the wholly owned subsidiary channeling the 209 million yuan injection to the project.
Corteva and Globachem Form 50/50 Crop Protection Joint Venture
Corteva and Belgium's Globachem N.V. announced a definitive agreement on September 9 to form a 50/50 joint venture to develop and commercialize new crop protection products for farmers in Europe and the Americas. The deal builds on an existing multi-year relationship, with Corteva contributing late-pipeline and commercial-stage technology and Globachem providing formulation and regulatory expertise, and the venture will operate independently with products commercializable by either or both parents. The transaction still requires regulatory clearance and is targeted to close in the fourth quarter of 2026, with new solutions not expected to launch until the early 2030s. The announcement comes as Corteva's crop protection business is set to spin off as a standalone public company, Vylor, on October 1, and as Corteva reported first-half 2026 net sales up 4% to $11.28 billion and operating EBITDA up 10% to $3.70 billion, though Crop Protection pricing fell 3% in the first half and 4% in the second quarter on Latin American competition. Corteva is also absorbing separation costs, including a $25 million headwind from separation-related timing already built into its full-year guidance.
CTVA · Capital · Positive Corteva forms a 50/50 JV with Globachem to develop and commercialize new crop protection products, contributing late-pipeline technology.
CTVA · Pricing · Negative Crop Protection pricing fell 3% in H1 and 4% in Q2 on Latin American competition.
Globachem N.V. · Capital · Positive Globachem forms a 50/50 JV with Corteva, contributing formulation and regulatory expertise to commercialize new crop protection products.
Vylor Inc. · Capital · Neutral Vylor is the crop protection spinoff of Corteva, mentioned only as context for the JV announcement.
Mosaic Launches Renuvis Enzara Enzyme Product After $273 Million Quarterly Loss
Mosaic Biosciences, a unit of The Mosaic Company, launched Renuvis Enzara, an enzyme-based treatment designed to speed up crop residue breakdown, on August 17, less than two weeks after Mosaic reported a second-quarter net loss of $273 million, a sharp reversal from the $411 million profit it posted in the same quarter of 2025. The product uses endoglucanase enzyme technology that works in soil as cold as 32 degrees Fahrenheit. Mosaic also trimmed its 2026 capital expenditure outlook to $1.2 billion from an earlier $1.25 billion, sold its Carlsbad, New Mexico, potash mine during the quarter, and lined up a $1 billion term loan to refinance and extend its short-term commercial paper, while keeping its regular dividend at $0.22 per share. Second-quarter revenue came in at $2.8 billion, but the company posted an operating loss of $36 million and adjusted EBITDA fell to $407 million from $566 million a year earlier, with Phosphate swinging to an operating loss of $104 million from a loss of $8 million and Mosaic Fertilizantes moving from operating earnings of $109 million to an operating loss of $41 million. Potash was the one stable segment, generating $278 million in adjusted EBITDA, essentially matching the $278 million it produced a year earlier.
MOS · Capital · Negative Mosaic reported a $273 million Q2 net loss, an operating loss, and sharply lower adjusted EBITDA, with Phosphate and Fertilizantes swinging to losses.
MOS · Technology · Positive Mosaic Biosciences launched Renuvis Enzara, an enzyme-based crop residue breakdown product using endoglucanase technology.
ScottsMiracle-Gro Redeems $250 Million in Notes, Renews $750 Million Facility
The Scotts Miracle-Gro Company announced a series of capital allocation moves, including the redemption of $250 million of senior notes, the renewal of a $750 million accounts receivable facility and the start of its $500 million share repurchase program, while reaffirming its fiscal 2026 financial guidance. The company redeemed the entire $250 million of its outstanding 5.25% senior notes due 2026 on Sept. 11, 2026, using revolver borrowings and planned excess fiscal 2026 free cash flow to reduce leverage and strengthen the balance sheet. It also renewed its $750 million accounts receivable facility with JPMorgan Chase Bank, N.A., extending its maturity to Aug. 31, 2027. Under the $500 million share repurchase program, ScottsMiracle-Gro bought back $25 million of shares in August 2026, with future repurchases subject to market conditions and the company's debt-reduction priorities. The company said it has achieved its fiscal 2026 free cash flow target of $275 million, a level it expects to help bring leverage down to the high-3x range.
SMG · Capital · Positive ScottsMiracle-Gro redeemed $250M of senior notes, renewed its $750M receivables facility, and began a $500M buyback while reaffirming FY2026 guidance and hitting its $275M free cash flow target
Corteva Board Approves Vylor Seed Spin-Off as State Attorneys General Challenge PFAS Liability Move
Corteva won Board approval to spin off its seed segment as Vylor Inc., with a planned NYSE listing and all Vylor shares to be distributed to existing Corteva shareholders as part of the separation structure. State Attorneys General have filed legal action claiming the Vylor spin-off is intended to sidestep PFAS related liabilities, setting up a pivotal moment for Corteva investors. The separation carves the seed segment into Vylor, leaving New Corteva more focused on crop protection and related partnerships such as the Globachem joint venture. Corteva, which carries a market value of about $55.1b, has set a planned October 1, 2026 Vylor listing timeline, and investors are watching whether courts allow the distribution to proceed as announced and how management updates PFAS related obligations between Corteva, Vylor and existing Chemours or DuPont agreements. The article also cites a $92.40 fair value estimate for Corteva.
CTVA · Regulation · Neutral Board approved the Vylor seed spin-off, but state AGs' PFAS liability lawsuit challenges whether the distribution can proceed.
Vylor Inc. · Regulation · Neutral Newly approved seed spin-off with planned NYSE listing, but its distribution hinges on the PFAS liability legal challenge.
CC · Regulation · Neutral Mentioned only as a party to existing PFAS agreements whose obligations may be updated amid the Vylor spin-off.
Bioceres Q4 Revenue Stabilizes at $55.9 Million as Full-Year Sales Fall 18%
Bioceres Crop Solutions reported fourth-quarter revenue of $55.9 million, slightly above the $55.4 million posted a year earlier, while full-year fiscal 2026 revenue declined 18% to $238 million. Fourth-quarter Crop Nutrition revenue rose 36% year-over-year on strong microbeaded fertilizer performance, offsetting lower crop protection and seed sales, but reported gross profit slipped 6% to $12.7 million at a 22.8% margin after roughly $4 million in non-recurring inventory obsolescence charges. Adjusted EBITDA for the quarter turned positive at $0.6 million, an improvement of about $10 million from negative $9.6 million a year earlier, as SG&A fell 19%, while full-year adjusted EBITDA declined 12% to $25.5 million from $28.9 million. Total financial debt stood at $225.9 million as of June 30 against $12.2 million in cash and short-term investments, leaving net financial debt of $213.6 million, with $118.6 million of secured notes classified as short-term amid an ongoing acceleration dispute with noteholders. The company reprofiled approximately $28 million of bank debt obligations at Rizobacter and completed a voluntary maturity extension for $46.5 million in aggregate principal of local bonds in Argentina, and it is targeting roughly 40% gross margins from fiscal 2027 onward and combined SG&A of 23% of revenues by fiscal 2028.
BIOX · Capital · Neutral Q4 revenue stabilized but full-year sales fell 18%, gross profit slipped on inventory charges, and net debt of $213.6M with an ongoing noteholder acceleration dispute weighs on the story.
ScottsMiracle-Gro Redeems $250 Million Notes, Starts $500 Million Buyback
Scotts Miracle-Gro announced the execution of key capital allocation initiatives, including the redemption of all $250 million aggregate principal amount of its outstanding 5.250% senior notes due 2026, a move completed on September 11, 2026 and funded through a combination of available revolver debt and planned fiscal year 2026 excess free cash flow. The company also renewed its $750 million accounts receivable facility with JPMorgan Chase Bank, N.A., extending its maturity to August 31, 2027. In addition, ScottsMiracle-Gro executed $25 million in share repurchases during August, marking the start of its $500 million share repurchase program authorized by the Board of Directors, though the company said the timing and scale of future repurchases remain secondary to its commitment to ongoing debt reduction. The company reaffirmed its full Fiscal 2026 guidance, including U.S. Consumer net sales low single-digit growth, non-GAAP adjusted gross margin of at least 32%, non-GAAP adjusted net income per share from continuing operations of $4.30 to $4.45, non-GAAP adjusted EBITDA mid single-digit growth, and free cash flow of $275 million, driving its leverage ratio down to the high 3s. ScottsMiracle-Gro will close its fiscal year on September 30, 2026, and announce full-year financial results on November 4, 2026.
Intrepid Potash Posts Q2 Results as Trio Cost Cuts Fund Bigger Buyback
Intrepid Potash reported second-quarter results on August 4 that leaned on its Trio segment, where cost per ton fell to $205, the lowest since the fourth quarter of 2019, helping lift gross margin 35% from a year earlier even as total sales from continuing operations dipped slightly. Trio sales climbed 8% to $35.7 million on flat volumes of 70 thousand tons, driven by a 6% rise in the average realized price to $389 per ton, while production rose 7% to 75 thousand tons and Trio gross margin reached $11.4 million from $8.1 million a year ago. Intrepid raised full-year Trio production guidance to 295 thousand to 305 thousand tons and potash guidance to 290 thousand to 300 thousand tons, and the board expanded the share repurchase authorization to $50 million, backed by $185.0 million in cash and equivalents as of June 30 with no borrowings outstanding. The potash segment lagged, with sales volumes down 14% to 59 thousand tons and cost per ton up to $359 from $337, leaving potash gross margin essentially flat at a gain of just $0.1 million. The completed sale of Intrepid South added $62.0 million in cash and a $13.2 million after-tax gain, while a $5.0 million loss contingency tied to the Pecos water rights matter weighed on results and net income from continuing operations came in at $2.4 million.
IPI · Capital · Positive Q2 results show Trio cost per ton at $205 lifting gross margin 35%, plus board expanded buyback to $50M backed by $185M cash.
IPI · Demand · Positive Trio sales climbed 8% to $35.7M on a 6% rise in average realized price to $389/ton, and full-year Trio and potash production guidance was raised.
Nutrien Shares Rally 17.2% on Record Potash Volumes and Raised Guidance
Nutrien Limited's NTR shares have rallied 17.2% over the past month, outpacing the Zacks Fertilizers industry's 16.8% growth over the same period, on strong fertilizer market fundamentals, higher potash and nitrogen prices and improved cost efficiency. First-half 2026 potash sales volumes reached a record 7.45 million tons, and full-year potash sales volume guidance was raised to 14.2-14.8 million tons, while management expects global potash shipments of 74-77 million tons in 2026. Potash average net selling price rose 13% year over year to $266 per ton in the first half and nitrogen average net selling price climbed 14% to $416 per ton, lifting Potash adjusted EBITDA 15% to $1.24 billion and Nitrogen adjusted EBITDA 4% to $1.12 billion. Proprietary products gross margin increased 18% year over year to $843 million, helping Retail adjusted EBITDA rise 4% to $1.24 billion, with 2026 Retail adjusted EBITDA guidance maintained at $1.75-$1.95 billion. Management lowered 2026 capital expenditures guidance to $1.95-$2.05 billion from $2-$2.1 billion, citing capital efficiency and structural free cash flow growth, and NTR currently carries a Zacks Rank #3 (Hold).
Kumiai Chemical cuts fiscal 2026 net profit forecast to 4 billion yen on generic entry impairment
Kumiai Chemical Industry said on the 11th that it has revised down its consolidated net profit forecast for the fiscal year ending October 2026 to 4 billion yen from the previous 6.4 billion yen. It had previously expected a profit increase, but now anticipates an 8.7% decline from the prior year. In addition to an inventory valuation loss tied to generic competition for its overseas herbicide Axeev, special losses including impairment of fixed assets and restructuring costs are also weighing on net profit. The operating profit forecast was cut to 2.7 billion yen from the previous 7.2 billion yen. Meanwhile, the sales forecast was raised to 175 billion yen from the previous 162 billion yen on higher sales volumes.
4996.JP · Capital · Negative Cuts fiscal 2026 net profit forecast to 4 billion yen from 6.4 billion on impairment, restructuring costs, and inventory valuation loss.
4996.JP · Demand · Positive Raises sales forecast to 175 billion yen from 162 billion on higher sales volumes.
DuPont, Chemours, Corteva to Pay $455M in North Carolina PFAS Settlement
DuPont de Nemours, Chemours and Corteva have agreed to pay $455 million to settle PFAS contamination claims in North Carolina, including discharges tied to the Fayetteville Works manufacturing site. The settlement resolves lawsuits brought by the state and 11 local governments near the plant, and also covers certain statewide claims involving PFAS contamination from other sources, including firefighting foam. Payments will be made over 15 years, beginning within 30 days of the agreement's execution, and the companies estimated the payments have a combined net present value of about $355 million. Of the $455 million total, $18 million is attributed to contamination allegations not connected to Fayetteville Works, with no more than $14.4 million of that amount relating to aqueous film-forming foam, or AFFF. DuPont's pre-tax share has a present value of about $126 million, with 44%, or roughly $55 million, to be reimbursed by Qnity Electronics, leaving DuPont with an effective share of about $71 million before taxes and other adjustments; DuPont said its portion is largely covered by existing reserves. The agreement remains subject to the dismissal of the covered lawsuits, and the companies said PFAS remains a continuing legal risk, citing pending or potential personal-injury cases, natural-resource damage claims, remediation obligations and changing environmental regulations.
CC · Regulation · Negative Chemours is a party to the $455M North Carolina PFAS settlement resolving state and local contamination lawsuits tied to Fayetteville Works.
CTVA · Regulation · Negative Corteva is a party to the $455M PFAS settlement resolving North Carolina contamination claims, with continuing legal risk noted.
DD · Regulation · Negative DuPont agreed to pay its share of the $455M PFAS settlement, with an effective pre-tax share of about $71M largely covered by existing reserves.
Syngenta and Amoéba Sign Exclusive European Biofungicide Deal
Syngenta Crop Protection AG and Amoéba have announced an exclusive supply and distribution agreement for a next-generation biocontrol fungicide, formulation AXP20, targeting cereal diseases across the European Union, the United Kingdom, Ukraine, and Switzerland. The binding long-term partnership, which converts a November 2025 memorandum of understanding, covers all cereals except corn and aims to control septoria tritici blotch and yellow rust, which together affect an estimated 9 to 12 million hectares annually. First market registrations are expected in the third quarter of 2028, with initial sales in core EU markets by the end of that year for spring 2029 use. The product, based on the lysate of the amoeba Willaertia magna C2c Maky, received EU approval in 2025 and is classified under FRAC Group BM02 with low resistance risk. Amoéba's managing director, Jean-Marc Petat, called the agreement a defining milestone, noting that Syngenta's screening selected AXP20 as the highest performing biofungicide among many biological solutions.
ALMIB.PA · Demand · Positive Amoéba signs exclusive long-term supply and distribution deal with Syngenta for its AXP20 biofungicide across European cereals
先正达集团股份有限公司 (Syngenta Group Co., Ltd.) · Demand · Positive Syngenta secures exclusive distribution rights to a next-generation biofungicide targeting septoria and yellow rust across 9-12 million hectares
ADAMA Secures First EU Registration for Ferrabait Molluscicide
ADAMA Ltd. announced that its innovative molluscicide Ferrabait, based on the novel Feralla active ingredient, has received its first European Union product registration in Latvia, paving the way for commercial launches across Europe beginning in 2027 with France, Sweden, and Lithuania. The product, approved for use in cereals, rapeseed, potatoes, and high-value vegetables, delivers rapid control of slugs and snails within three days of application, addressing increased pest pressure from milder winters. Ferrabait leverages ADAMA's proprietary Desidro Technology to produce durable, mold-resistant pellets that outperform leading ferric phosphate competitors in wet conditions. The Feralla active ingredient was approved by the EU as a low-risk substance in 2025, and the formulation includes 12 components to enhance bait attractiveness while supporting sustainability goals. Germain Boulay, ADAMA's Global Head of Herbicides and Molluscicides, highlighted the product as an additional tool for growers facing regulatory and sustainability pressures.
The Scotts Miracle-Gro Company is expanding its soil amendment portfolio by acquiring the Black Kow brand, a move that supports its multi-year SMG 2.0 growth plan. The acquisition follows an existing agreement under which SMG has been the exclusive producer, distributor, and marketer of Black Kow since January 2026, with an option to buy. The company has announced its intention to exercise that option, with the deal expected to close in October; terms were not disclosed. Management expects the transaction to contribute to top-line sales while maintaining the company's margin profile, and it is described as a low-risk investment that should be accretive to earnings per share starting in the first year. The Black Kow brand, a trusted 57-year-old name in soil amendments, will be scaled through innovation and expanded nationwide, supporting SMG's fiscal 2027-2029 growth targets of 2-4% annual net sales growth, 50-100 basis points of adjusted gross margin improvement, 5-8% adjusted EPS growth, and free cash flow above $275 million.
Hualu Hengsheng to shut units for about 20 days from September 8, expected revenue impact of 230 million yuan
Shandong Hualu Hengsheng Chemical announced that starting September 8, 2026, it will shut down a coal gasification unit and some product production units for maintenance, expected to take about 20 days. This will affect the company's operating revenue by approximately 230 million yuan, accounting for 0.69% of the full-year revenue budget. The company said the maintenance is part of its annual plan and will not affect completion of the 2026 production plan.
600426.CG · Supply · Negative Shutting coal gasification and product units for ~20 days of maintenance will cut output and reduce operating revenue by about 230 million yuan.
Meibang Shares Plans to Increase Capital in Nuozheng Bio by 80 Million Yuan and Set Up Hong Kong Subsidiary
Meibang Shares announced that its board of directors has approved a plan to increase capital in its wholly owned subsidiary Nuozheng Bio by 80 million yuan using its own funds. After the capital increase, Nuozheng Bio's registered capital will rise from 100 million yuan to 180 million yuan, with the company's shareholding ratio remaining at 100 percent. Nuozheng Bio is mainly engaged in chemical pesticide production and biopesticide technology research and development. At the same time, the company plans to use 1 million US dollars of its own funds to establish a wholly owned subsidiary in Hong Kong, with registered capital of 500,000 Hong Kong dollars. Its business scope will cover outbound investment holding, international trade, supply chain management, and operations related to crop protection products.
605033.CG · Capital · Positive Board approved an 80 million yuan capital increase into wholly owned subsidiary Nuozheng Bio plus a $1M Hong Kong subsidiary, a financing/investment event.
Huachang Chemical's Control Acquisition Riddled with Doubts, Share Price Sees One-Day Wonder
After Huachang Chemical disclosed its detailed equity change report for the control acquisition, the share price staged a one-day wonder, falling 9.69 percent on September 3 to close at 6.43 yuan per share, approaching the transfer price of 6.18 yuan per share. The acquirer's actual controller Cheng Renjie's core industrial platform Xuanli Environmental Protection has a debt-to-asset ratio of nearly 70 percent, interest-bearing debt of nearly 5 billion yuan, and net profit halved, yet it is expected to support a cash acquisition of 1.413 billion yuan, raising doubts about the source of funds. Jiangsu Ruihua Charitable Foundation contributed 300 million yuan to participate in the acquisition, but its investment decision-making procedures and compliance have not been disclosed. In addition, the listed company's supplier Bai Pingnv contributed 300 million yuan to become an indirect shareholder, and the fairness of related-party transactions under her dual identity remains to be observed. The transaction still needs to pass five approval procedures, with a closing deadline of October 31, 2026.
002274.CS · Capital · Negative Control acquisition is riddled with doubts over the acquirer's funding source and compliance, sending shares down 9.69% toward the transfer price.
新疆宣力环保能源股份有限公司 · Capital · Negative Xuanli Environmental, the acquirer's core platform, has a ~70% debt ratio, nearly 5 billion yuan interest-bearing debt, and halved net profit yet must fund a 1.413 billion yuan cash acquisition.
Meibang Shares Plans to Increase Capital by 80 Million Yuan and Establish Hong Kong Subsidiary
Meibang Shares announced that its board of directors has approved a proposal to increase capital in its wholly-owned subsidiary Shaanxi Nuozheng Biotechnology Co., Ltd. by 80 million yuan, and to invest in establishing a wholly-owned Hong Kong subsidiary with registered capital of 500,000 Hong Kong dollars, with the company holding 100% equity.
605033.CG · Capital · Positive Board approved an 80 million yuan capital increase into its wholly-owned biotech subsidiary and the establishment of a wholly-owned Hong Kong subsidiary.
OCI N.V. Faces Legal Challenge to Orascom Construction Deal
OCI Global N.V. has received a petition from Value8 N.V. seeking an inquiry into its affairs and interim measures that could block a shareholder vote on its proposed combination with Orascom Construction PLC. The company, which trades on Euronext as OCI, says the petition largely repeats allegations from ongoing proceedings and believes it is without merit. OCI is reviewing the petition with legal advisers and will respond through appropriate channels, while reaffirming its focus on executing its announced strategy and previously communicated transactions.
OCI.AS · Regulation · Negative Value8 petition seeks inquiry and interim measures that could block the shareholder vote on OCI's Orascom Construction combination
VALUE.AS · Regulation · Neutral Value8 filed the petition seeking an inquiry into OCI's affairs and measures to block the deal vote
ScottsMiracle-Gro announced it will acquire the Black Kow brand, exercising a purchase option under a licensing agreement with owner Organics Management, with the deal expected to close in October. The acquisition supports the company's SMG 2.0 growth strategy and its mid-range financial targets for fiscal 2027 through 2029, which include annual net sales growth of 2 to 4 percent, adjusted gross margin improvement of 50 to 100 basis points, adjusted EPS growth of 5 to 8 percent, and free cash flow above $275 million. CEO Nate Baxter said the company will scale the 57-year-old brand and expand its national availability, while CFO Mark Scheiwer noted the deal is low-risk, accretive to EPS from year one, and consistent with margin and leverage targets. Black Kow, a leading soil amendment brand, will complement Miracle-Gro's premium products and expand the portfolio with organic amendments and specialty soils.
SMG · Capital · Positive ScottsMiracle-Gro exercises a purchase option to acquire the Black Kow brand, an accretive M&A deal supporting its SMG 2.0 growth strategy and fiscal 2027-2029 targets.
Organics Management · Capital · Neutral Organics Management, owner of Black Kow, is selling the brand to ScottsMiracle-Gro; terms and impact on Organics Management are not disclosed.
Tianhe Shares Deputy General Manager Ye Jiancai Resigns Due to Position Adjustment
Guangdong Tianhe Agricultural Means of Production Co., Ltd. announced that Deputy General Manager Ye Jiancai has applied to resign from the position of deputy general manager due to a position adjustment. After resigning, he will no longer hold any position in the company or its subsidiaries. The resignation report takes effect from the date it is delivered to the board of directors. As of the disclosure date of the announcement, Ye Jiancai holds 60,000 shares of the company, accounting for 0.02% of the company's share capital, and his shares will continue to be managed in accordance with regulations. The company's board of directors expressed gratitude for his contributions during his tenure and stated that the resignation will not have an adverse impact on daily operations and management.
United States
